tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Low, 4 are a HOLD (16%), 19 are a BUY (76%), 2 are a SELL (8%).
Analyst David Low, currently employed at JPMORGAN, carries an average stock price target met ratio of 100% that have a potential upside of 10.41% achieved within 363 days.
David Low’s has documented 42 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 23-Apr-2025.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for RMD (RESMED) at 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $24.08 (12.35%) receiving and performance score of 5.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$330
$61.91 (23.09%)
$285
1 months 3 days ago
(17-Sep-2025)
7/8 (87.5%)
$56.71 (20.75%)
38
Buy
$270
$1.91 (0.71%)
$250
3 months 5 days ago
(15-Jul-2025)
14/14 (100%)
$16.28 (6.42%)
98
Buy
$290
$21.91 (8.17%)
5 months 27 days ago
(23-Apr-2025)
17/17 (100%)
$54.9 (23.35%)
363
Hold
$248
$-20.09 (-7.49%)
$260
5 months 27 days ago
(23-Apr-2025)
3/3 (100%)
$12.9 (5.49%)
70
Hold
$240
$-28.09 (-10.48%)
$250
7 months 16 days ago
(04-Mar-2025)
2/2 (100%)
$17.12 (7.68%)
54
What Year was the first public recommendation made by David Low?
